Peng Z - Search Results

1

Virus-like particles presenting interleukin-33 molecules: immunization characteristics and potentials of blockingIL-33/ST2 pathway in allergic airway inflammation.

Long Q, Huang W, Yao Y, Yang X, Sun W, Jin X, Li Y, Chu X, Liu C, Peng Z, Ma Y. Long Q, et al. Among authors: peng z. Hum Vaccin Immunother. 2014;10(8):2303-11. doi: 10.4161/hv.29425. Hum Vaccin Immunother. 2014. PMID: 25424936 Free PMC article.

2

Immunization against TGF-β1 reduces collagen deposition but increases sustained inflammation in a murine asthma model.

Ma Y, Huang W, Liu C, Li Y, Xia Y, Yang X, Sun W, Bai H, Li Q, Peng Z. Ma Y, et al. Among authors: peng z. Hum Vaccin Immunother. 2016 Jul 2;12(7):1876-85. doi: 10.1080/21645515.2016.1145849. Epub 2016 Feb 22. Hum Vaccin Immunother. 2016. PMID: 26901684 Free PMC article.

3

An IL-17 peptide-based and virus-like particle vaccine enhances the bioactivity of IL-17 in vitro and in vivo.

Guan Q, Weiss CR, Qing G, Ma Y, Peng Z. Guan Q, et al. Among authors: peng z. Immunotherapy. 2012 Dec;4(12):1799-807. doi: 10.2217/imt.12.129. Immunotherapy. 2012. PMID: 23240747

4

A potential immunotherapy approach: mucosal immunization with an IL-13 peptide-based virus-like particle vaccine in a mouse asthma model.

Ma Y, Ma AG, Peng Z. Ma Y, et al. Among authors: peng z. Vaccine. 2007 Nov 19;25(47):8091-9. doi: 10.1016/j.vaccine.2007.09.009. Epub 2007 Sep 20. Vaccine. 2007. PMID: 17935839

5

Novel recombinant interleukin-13 peptide-based vaccine reduces airway allergic inflammatory responses in mice.

Ma Y, HayGlass KT, Becker AB, Fan Y, Yang X, Basu S, Srinivasan G, Simons FE, Halayko AJ, Peng Z. Ma Y, et al. Among authors: peng z. Am J Respir Crit Care Med. 2007 Sep 1;176(5):439-45. doi: 10.1164/rccm.200610-1405OC. Epub 2007 Jun 7. Am J Respir Crit Care Med. 2007. PMID: 17556715

6

Enhancement of IL-10 bioactivity using an IL-10 peptide-based vaccine exacerbates Leishmania major infection and improves airway inflammation in mice.

Zhou G, Ma Y, Jia P, Guan Q, Uzonna JE, Peng Z. Zhou G, et al. Among authors: peng z. Vaccine. 2010 Feb 17;28(7):1838-46. doi: 10.1016/j.vaccine.2009.11.081. Epub 2009 Dec 14. Vaccine. 2010. PMID: 20005853

7

Employing an IL-23 p19 vaccine to block IL-23 ameliorates chronic murine colitis.

Guan Q, Burtnick HA, Qing G, Weiss CR, Ma AG, Ma Y, Warrington RJ, Peng Z. Guan Q, et al. Among authors: peng z. Immunotherapy. 2013 Dec;5(12):1313-22. doi: 10.2217/imt.13.141. Immunotherapy. 2013. PMID: 24283842

8

Targeting IL-12/IL-23 by employing a p40 peptide-based vaccine ameliorates TNBS-induced acute and chronic murine colitis.

Guan Q, Ma Y, Hillman CL, Qing G, Ma AG, Weiss CR, Zhou G, Bai A, Warrington RJ, Bernstein CN, Peng Z. Guan Q, et al. Among authors: peng z. Mol Med. 2011;17(7-8):646-56. doi: 10.2119/molmed.2010.00252. Epub 2011 Mar 11. Mol Med. 2011. PMID: 21424108 Free PMC article.

9

Development of recombinant vaccines against IL-12/IL-23 p40 and in vivo evaluation of their effects in the downregulation of intestinal inflammation in murine colitis.

Guan Q, Ma Y, Hillman CL, Ma A, Zhou G, Qing G, Peng Z. Guan Q, et al. Among authors: peng z. Vaccine. 2009 Nov 23;27(50):7096-104. doi: 10.1016/j.vaccine.2009.09.058. Epub 2009 Sep 26. Vaccine. 2009. PMID: 19786142

10

Sustained suppression of IL-13 by a vaccine attenuates airway inflammation and remodeling in mice.

Ma Y, Halayko AJ, Basu S, Guan Q, Weiss CR, Ma AG, HayGlass KT, Becker AB, Warrington RJ, Peng Z. Ma Y, et al. Among authors: peng z. Am J Respir Cell Mol Biol. 2013 May;48(5):540-9. doi: 10.1165/rcmb.2012-0060OC. Am J Respir Cell Mol Biol. 2013. PMID: 23470628

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

8,185 results

Search Page

Filters